Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
TCR2 THERAPEUTICS INC. ()
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
25 May 2023
TANG KEVIN C
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
4,394,800
+1%
50,000
$1.72
$86,000.00
SELL
22 May 2023
MPM ASSET MANAGEMENT LLC
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
304,001
-18%
70,170
$1.88
$131,919.60
SELL
22 May 2023
GADICKE ANSBERT
Director, 10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
304,001
-18%
70,170
$1.88
$131,919.60
BUY
3 May 2023
TANG KEVIN C
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
4,144,800
+7%
289,577
$1.89
$547,943.56
SELL
9 Dec 2022
Menzel Garry E
President and CEO, Director, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
138,871
-18%
31,938
$1.10
$35,033.88
SELL
9 Dec 2022
Justice Angela
Chief People Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
51,708
-14%
8,620
$1.10
$9,447.68
SELL
9 Dec 2022
Olagunju Peter
Chief Technical Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
24,092
-16%
4,830
$1.10
$5,298.50
SELL
9 Dec 2022
Cardama Alfonso Quintas
Chief Medical Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
109,459
-11%
13,799
$1.10
$15,122.82
SELL
7 Dec 2022
Olagunju Peter
Chief Technical Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
28,922
-8%
2,788
$1.27
$3,533.33
SELL
7 Dec 2022
Menzel Garry E
President and CEO, Director, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
170,809
-9%
18,425
$1.27
$23,360.06
SELL
7 Dec 2022
Justice Angela
Chief People Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
57,365
-7%
4,968
$1.27
$6,301.18
SELL
7 Dec 2022
Cardama Alfonso Quintas
Chief Medical Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
123,258
-6%
7,942
$1.27
$10,081.21
SELL
5 Dec 2022
Justice Angela
Chief People Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
62,333
-6%
4,663
$1.35
$6,310.22
SELL
5 Dec 2022
Cardama Alfonso Quintas
Chief Medical Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
131,200
-5%
7,464
$1.35
$10,089.67
SELL
5 Dec 2022
Olagunju Peter
Chief Technical Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
31,710
-7%
2,618
$1.35
$3,531.00
SELL
5 Dec 2022
Menzel Garry E
President and CEO, Director, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
189,234
-11%
23,416
$1.36
$31,784.37
SELL
1 Dec 2022
Justice Angela
Chief People Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
66,996
-3%
2,273
$1.39
$3,161.74
SELL
1 Dec 2022
Menzel Garry E
President & CEO, Director, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
212,650
-3%
8,408
$1.39
$11,687.12
SELL
1 Dec 2022
Olagunju Peter
Chief Technical Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
34,328
-3%
1,273
$1.39
$1,765.65
SELL
1 Dec 2022
Cardama Alfonso Quintas
Chief Medical Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
138,664
-2%
3,636
$1.39
$5,054.04
SELL
14 Dec 2020
Somaiya Mayur Ian
Chief Financial Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
1,473
-57%
2,000
$35.00
$70,000.00
SELL
17 Nov 2020
Somaiya Mayur Ian
Chief Financial Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
3,139
-53%
3,666
$30.00
$109,980.00
SELL
12 Nov 2020
Hofmeister Robert
Chief Scientific Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
38,850
-33%
20,000
$25.10
$502,000.00
SELL
29 Oct 2020
Hofmeister Robert
Chief Science Officer, Officer
TCR2 THERAPEUTICS INC.
(TCRR)
38,850
-33%
20,000
$19.10
$382,000.00
SELL
20 Dec 2019
Baeuerle Patrick
Director
TCR2 THERAPEUTICS INC.
(TCRR)
350,786
-25%
116,929
$15.36
$1,796,417.50
SELL
18 Dec 2019
Jovan-Embiricos Morana
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
82,575
-35%
44,856
$16.51
$740,386.60
SELL
9 Dec 2019
Jovan-Embiricos Morana
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
361,665
-36%
204,562
$17.64
$3,609,169.50
SELL
7 Nov 2019
Gibson Neil W
Director
TCR2 THERAPEUTICS INC.
(TCRR)
0
-100%
79,640
$6.59
$525,187.60
SELL
22 Oct 2019
Jovan-Embiricos Morana
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
392,185
-0%
3,888
$15.16
$58,930.81
SELL
20 Sep 2019
Jovan-Embiricos Morana
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
392,765
-51%
416,321
$17.92
$7,459,819.50
SELL
21 Aug 2019
Jovan-Embiricos Morana
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
102,563
-38%
64,104
$17.11
$1,097,079.90
BUY
19 Feb 2019
MPM BioVentures 2014, L.P.
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
4,050,865
+21%
706,666
$15.00
$10,599,990.00
BUY
19 Feb 2019
Jovan-Embiricos Morana
Director, 10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
200,000
+142%
666,667
$15.00
$10,000,005.00
BUY
19 Feb 2019
UBS Oncology Impact Fund L.P.
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
3,370,982
+24%
666,667
$15.00
$10,000,005.00
BUY
19 Feb 2019
Upnorth Investment Ltd
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
2,137,419
+10%
200,000
$15.00
$3,000,000.00
BUY
19 Feb 2019
MPM SunStates Fund, L.P.
10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
4,050,865
+21%
706,666
$15.00
$10,599,990.00
BUY
19 Feb 2019
GADICKE ANSBERT
Director, 10% Owner
TCR2 THERAPEUTICS INC.
(TCRR)
1,569,235
+701%
1,373,333
$15.00
$20,599,996.00
Home